Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| RMNI | 8-K | bullish | 6/10 | Rimini Street reported Q3 2026 revenue of $112.1M (up 8.3% YoY) and GAAP EPS of $0.07, exceeding consensus estimates of | Oct 29, 2026 |
| FBIZ | 8-K | bullish | 6/10 | First Business Financial Services reported record Q3 2026 net income available to common shareholders of $16.4M ($1.95 E | Oct 29, 2026 |
| PRTS | 8-K | neutral | 5/10 | CarParts.com reported Q3 2026 net sales of $129.3M, up 1.2% YoY, and a GAAP net loss of ($4.1M) or ($0.53) per share, im | Oct 29, 2026 |
| RMD | 8-K | bullish | 6/10 | ResMed reported Q1 FY2027 results with revenue of $1.415B (up 6% reported, 7% core constant currency) and GAAP diluted E | Oct 29, 2026 |
| DVA | PRESS-RELEASE | bullish | 6/10 | DaVita reported Q3 2026 adjusted diluted EPS of $3.82, above the $3.57 consensus, on revenues of $3.578B versus the $3.5 | Oct 29, 2026 |
| PEN | PRESS-RELEASE | neutral | 5/10 | Penumbra reported Q3 2026 revenue of $410.1M, up 15.6% YoY and above the $400.1M consensus, with GAAP diluted EPS of $1. | Oct 29, 2026 |
| REAL | PRESS-RELEASE | bullish | 6/10 | The RealReal reported Q3 2026 revenue of $206M, beating the $196.9M consensus, with GMV up 23% YoY and total revenue up | Oct 29, 2026 |
| ILMN | PRESS-RELEASE | bullish | 6/10 | Illumina reported Q3 2026 revenue of $1.13B (up 4.2% YoY) and GAAP diluted EPS of $1.43, beating the consensus estimate | Oct 29, 2026 |
| FISI | PRESS-RELEASE | bearish | 5/10 | Financial Institutions, Inc. reported Q3 2026 diluted EPS of $0.99, missing the $1.05 consensus by 5.7%, while revenue o | Oct 29, 2026 |
| MMSI | PRESS-RELEASE | bullish | 6/10 | Merit Medical reported Q3 2026 revenue of $416.2M (up 8.4% YoY) and non-GAAP EPS of $1.12 (up 22% YoY), beating consensu | Oct 29, 2026 |
| IMRX | PRESS-RELEASE | neutral | 5/10 | Immuneering reported Q3 2026 net loss of $24.2M ($0.37 per share), wider than the $15.0M loss a year ago, as R&D spendin | Oct 29, 2026 |
| EXPO | PRESS-RELEASE | bullish | 6/10 | Exponent reported Q3 2026 revenue of $173.7M (up 18% YoY) and GAAP diluted EPS of $0.64 (up from $0.55), both above cons | Oct 29, 2026 |
| SYK | PRESS-RELEASE | bearish | 6/10 | Stryker reported Q3 2026 adjusted EPS of $3.52, slightly below the $3.55 consensus, on revenue of $6.52B versus the $6.6 | Oct 29, 2026 |
| CVLG | PRESS-RELEASE | neutral | 5/10 | Covenant Logistics reported Q3 2026 GAAP EPS of $0.40 and adjusted EPS of $0.50, beating the $0.43 consensus on an adjus | Oct 29, 2026 |
| SPXC | PRESS-RELEASE | bullish | 6/10 | SPX Technologies reported Q3 2026 adjusted EPS of $2.21, beating the $2.09 consensus by 5.7%, and revenue of $714.5M, ab | Oct 29, 2026 |
| CLBK | PRESS-RELEASE | mixed | 6/10 | Columbia Financial reported Q3 2026 GAAP net income of $5.2M ($0.02 per share), down sharply from $14.9M ($0.07) a year | Oct 29, 2026 |
| MSEX | PRESS-RELEASE | bullish | 6/10 | Middlesex Water reported Q3 2026 diluted EPS of $0.95 on revenue of $60.2M, beating consensus estimates of $0.86 and $59 | Oct 29, 2026 |
| RMD | PRESS-RELEASE | bullish | 6/10 | Resmed reported Q1 FY2027 revenue of $1.415B (up 6% YoY, 7% core constant currency) and non-GAAP diluted EPS of $2.91 (u | Oct 29, 2026 |
| MDLZ | PRESS-RELEASE | neutral | 5/10 | Mondelez reported Q3 2026 adjusted EPS of $0.78, beating the $0.71 consensus by 9.9%, on revenue of $9.967B versus the $ | Oct 29, 2026 |
| SUPN | PRESS-RELEASE | neutral | 5/10 | Supernus Pharmaceuticals reported Q3 2026 total revenue of $226.8M, an 18% YoY increase, beating the $217.6M consensus. | Oct 29, 2026 |
| JCAP | PRESS-RELEASE | neutral | 2/10 | Jefferson Capital announced it will release Q3 2026 financial results after market close on November 12, 2026, followed | Oct 29, 2026 |
| MFIN | PRESS-RELEASE | bearish | 5/10 | Medallion Bank (MFIN subsidiary) reported Q3 2026 net interest income of $60.0M, in line with the $60.0M consensus, but | Oct 29, 2026 |
| CAKE | 144 | neutral | 2/10 | Scarlett May, an officer of Cheesecake Factory, filed a Form 144 notice of intent to sell 2,939 shares of common stock v | Oct 29, 2026 |
| PURE | 8-K | bearish | 4/10 | PURE Bioscience reported fiscal year 2026 total revenue of $2.318M, up 5.3% from $2.202M in fiscal 2025, but net loss wi | Oct 29, 2026 |
| NPB | CLUSTER | bullish | 5/10 | Four Northpointe Bancshares insiders, including the Chairman & CEO, made open-market purchases totaling $1.05M over the | Oct 29, 2026 |
| CRSF | NT 10-K | bearish | 6/10 | Crisp Momentum Inc. filed a late notification for its Form 10-K for the fiscal year ended July 31, 2026, citing addition | Oct 29, 2026 |
| NDAQ | CLUSTER | neutral | 2/10 | Three Nasdaq insiders sold a total of $1.60M in open-market sales over the past week, including the President of Market | Oct 29, 2026 |
| EXPO | 8-K | bullish | 6/10 | Exponent reported Q3 2026 revenue of $173.7M (up 18% YoY) and GAAP diluted EPS of $0.64 (up from $0.55), both above cons | Oct 29, 2026 |
| AMZN | 8-K | bullish | 6/10 | Amazon reported Q3 2026 net sales of $201.9B (+12% YoY) and operating income of $28.1B (+61% YoY), with operating margin | Oct 29, 2026 |
| FORR | 8-K | neutral | 5/10 | Forrester Research reported Q3 2026 adjusted EPS of $0.24, beating the $0.20 consensus, on revenue of $86.1M which also | Oct 29, 2026 |